For more than 130 years, Merck & Co. has stood at the forefront of scientific discovery, driven by a singular mission—to save and improve lives. As a global leader in biopharmaceutical innovation, Merck continues to shape the future of healthcare through groundbreaking medicines, vaccines, and a steadfast commitment to patients worldwide.
With a legacy rooted in research excellence, the company aspires to be the premier research-intensive biopharmaceutical organization, advancing solutions that address some of the most complex health challenges affecting both humans and animals.
A Legacy Built on Values
Merck’s enduring success is anchored in a strong foundation of values that guide every decision and action:
- Patients First: Every innovation begins with the goal of improving patient outcomes and expanding access to life-saving treatments.
- Respect for People: A diverse and inclusive workforce drives creativity, collaboration, and progress.
- Ethics and Integrity: The company upholds the highest standards of responsibility toward patients, partners, and communities.
- Innovation and Scientific Excellence: Continuous research and development fuel transformative breakthroughs in medicine.
These principles ensure that Merck not only advances healthcare but does so responsibly and sustainably.
Leading Innovation in Oncology
One of Merck’s most significant areas of focus is oncology, where it continues to push the boundaries of cancer treatment. Through cutting-edge research, the company is developing therapies designed to extend and improve the lives of patients facing various forms of cancer.
Key areas of innovation include:
- Cell-based therapies and immune cell engagers that target tumors more precisely
- Immune system stimulators that enhance the body’s natural defense mechanisms
- Personalized cancer vaccines tailored to individual patient profiles
- Tumor microenvironment research to better understand and disrupt cancer growth
These advancements reflect Merck’s commitment to delivering more effective and personalized treatment options in the fight against cancer.
Transforming Global Health Through Vaccines
Merck has been a pioneer in vaccine development for over a century, working to prevent diseases before they begin. Its vaccine programs are guided by science, collaboration, and a deep understanding of global health needs.
In partnership with organizations like Wellcome Trust, Merck supports initiatives such as the Hilleman Laboratories, which focus on making vaccines more accessible and affordable in low-income regions.
By collaborating with governments, researchers, and non-profits, Merck continues to play a vital role in combating infectious diseases and improving public health outcomes worldwide.
Advancing Infectious Disease Research
From early antibiotic discoveries to pioneering HIV research, Merck has long been a leader in addressing infectious diseases. Its efforts have contributed to significant advancements in understanding and treating conditions that impact millions globally.
The company remains deeply committed to:
- HIV research, with the ultimate goal of eradication
- Antibiotic development, addressing the growing threat of resistance
- Global disease response, including efforts against viruses like Ebola
Despite decades of progress, Merck continues to invest in innovative solutions to meet ongoing and emerging health threats.
Tackling Cardio-Metabolic Disorders
Merck’s impact extends to cardio-metabolic diseases, including cardiovascular conditions and Type 2 diabetes. These disorders represent some of the most pressing health challenges of the modern era.
With over 60 years of experience in this field, Merck continues to develop therapies that improve patient outcomes and address the underlying complexities of these conditions. Its research spans the entire lifecycle—from discovery to post-approval—ensuring continuous improvement in treatment approaches.
Leadership Driving Global Impact
At the helm of Merck is Robert M. Davis, Chairman and Chief Executive Officer. With extensive experience across finance, strategy, and operations, Davis has been instrumental in guiding the company’s global vision and strengthening its leadership in the biopharmaceutical industry.
Under his leadership, Merck continues to expand its research capabilities, enhance operational efficiency, and deliver meaningful innovation at scale.
A Future Powered by Science
Merck’s commitment to scientific advancement goes beyond laboratories—it extends into communities around the world. By fostering collaboration, investing in research, and prioritizing patient needs, the company is shaping a future where healthcare is more effective, accessible, and equitable.
As global health challenges evolve, Merck remains steadfast in its purpose: to harness the power of science to improve lives.
Looking Ahead
With a robust pipeline, a legacy of innovation, and a clear vision for the future, Merck is well-positioned to continue leading the biopharmaceutical industry. Its dedication to addressing unmet medical needs ensures that it will remain a critical force in advancing global health.
“Everything we do is rooted in our deep appreciation for life—and our commitment to using science to save and improve lives around the world.”
